Analyst/Investor Day July 15, 2026 9:00 AM EDTCompany ParticipantsJan-Hendrik Mohr - Chairman of Management Board & ...
An engineered enzyme cleaved and repaired age-related protein damage in human tissue, which was long thought to be irreversible in a proof-of-concept study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results